drugset / Trial / NCT06742853

A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

NCT06742853

Phase 1 Completed 81 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindTreatment

Summary

The main aim of this study is to assess the effects of AZD0780 when added on top of ezetimibe or ezetimibe and rosuvastatin or ezetimibe and bempedoic acid.

Timeline

Start
2024-12-20
Primary completion
2025-10-29
Completion
2025-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Laroprovstat Small molecule Oral
Background Bempedoic acid Small molecule 180 mg Oral
Background Ezetimibe Unknown 10 mg Oral
Background Rosuvastatin Small molecule 20 mg Oral

Indications